Skip to main content

Outcomes of Patients’ Evidence With Novel, Do-It-Yourself Artificial Pancreas Technology

Objective

Type 1 diabetes is a rare but highly challenging chronic condition which often leads to lowered life expectancy and greatly diminished quality of life even amongst those patients who are the most diligent and proactive in the practice of disease self-management. In recent years, there has been a growing movement of ‘patient innovators’ leading the development of self-built or ‘do-it-yourself’ artificial pancreas systems (DIYAPS), which help to automate day-to-day decision making needed for successful self-management. There is prima facie evidence to suggest that such systems can lead to improvements in glucose outcomes that far exceed those offered by the most state-of-the-art commercially available solutions. The aim of this RISE project is to tap into the expertise and knowledge shared by these communities by bringing together an intersectoral and interdisciplinary research team consisting of patient innovators, academic researchers, healthcare professionals (HCPs) and NGOs to establish an empirical evidence base surrounding the impact of DIYAPS. The exciting programme of research includes training and networking for participating staff designed to encourage inter-disciplinary thinking and broaden career horizons, while the dissemination and public outreach activities will ensure that project findings reach key stakeholders, such as policymakers, HCPs and industry, both within Europe and beyond. The key outcomes of this project will include a new model of knowledge co-creation and an evidence-base surrounding the potential scale-up of DIYAPS solutions that will have profound implications for those living with chronic conditions, their families, as well as healthcare systems and European society as a whole.

Field of science

  • /medical and health sciences/medical biotechnology/tissue engineering/artificial pancreas
  • /medical and health sciences/clinical medicine/endocrinology/diabetes

Call for proposal

H2020-MSCA-RISE-2018
See other projects for this call

Funding Scheme

MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

Coordinator

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Address
Belfield
4 Dublin
Ireland
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 331 200

Participants (6)

REGION HOVEDSTADEN
Denmark
EU contribution
€ 276 000
Address
Kongens Vaenge 2
3400 Hillerod
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Germany
EU contribution
€ 165 600
Address
Chariteplatz 1
10117 Berlin
Activity type
Higher or Secondary Education Establishments
T1INTERNATIONAL

Participation ended

United Kingdom
EU contribution
€ 0
Address
6 Little Pheasants
GL53 8EJ Cheltenham
Activity type
Other
FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL

Participation ended

Belgium
EU contribution
€ 0
Address
Chaussee De La Hulpe 166 Bloc C
1170 Bruxelles
Activity type
Other
DEDOC LABS GMBH
Germany
EU contribution
€ 138 000
Address
Stargarder Strasse 19
10437 Berlin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
KOBENHAVNS UNIVERSITET
Denmark
EU contribution
€ 110 400
Address
Norregade 10
1165 Kobenhavn
Activity type
Higher or Secondary Education Establishments

Partners (1)

DIABETES VICTORIA
Australia
Address
570 Elizabeth Street
3000 Melbourne
Activity type
Other